Prostatic neoplasia in transgenic mice with prostate‐directed overexpression of the c‐myc oncoprotein

No abstract is available for this paper.

• Publication year

  2000

• Venue

  The Prostate

• Publication date

  2000-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/1097-0045(20000601)43:4<278::AID-PROS7>3.0.CO;2-4PMID 10861747
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MYC oncogenes and human neoplastic disease

  1999cited by this paper
• The role of c-myc in cellular growth control

  1999cited by this paper
• Lobund‐Wistar rat model of prostate cancer in man

  1998cited by this paper
• The C3(1)/SV40 T Antigen Transgenic Mouse Model of Prostate and Mammary Cancer

  1998cited by this paper
• The Relationship Between Prostatic Intraepithelial Neoplasia and Prostate Cancer: Critical Issues

  1997cited by this paper
• Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.

  1997cited by this paper
• Abnormal prostate development in C3(1)‐bcl‐2 transgenic mice

  1997cited by this paper
• Large fragment of the probasin promoter targets high levels of transgene expression to the prostate of transgenic mice

  1997cited by this paper
• A Transgenic Mouse Prostate Cancer Model

  1996cited by this paper
• Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.

  1996cited by this paper
• The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice.

  1994cited by this paper
• Rodent models for targeted oncogenesis of the prostate gland

  1993cited by this paper
• Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.

  1993cited by this paper
• Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer.

  1992cited by this paper
• Enhanced expression of the c‐myc protooncogene in high‐grade human prostate cancers

  1988cited by this paper
• Expression of the c-myc protooncogene in human prostatic carcinoma and benign prostatic hyperplasia.

  1986cited by this paper

• Cooperativity of c-MYC with Krüppel-Like Factor 6 Splice Variant 1 induces phenotypic plasticity and promotes prostate cancer progression and metastasis

  2024cites this paper
• Molecular pathogenesis of prostate cancer

  2020cites this paper
• Phosphorylation of DEPDC5, a component of the GATOR1 complex, releases inhibition of mTORC1 and promotes tumor growth

  2019cites this paper
• Hyperglycemia and T Cell infiltration are associated with stromal and epithelial prostatic hyperplasia in the nonobese diabetic mouse

  2019cites this paper
• From genomics to functions: preclinical mouse models for understanding oncogenic pathways in prostate cancer.

  2019cites this paper
• Recent advances in prostate cancer research: large-scale genomic analyses reveal novel driver mutations and DNA repair defects

  2018cites this paper
• C.96-PROSTATE CANCER AND CADMIUM : A SILENT INODORE TOXIC PENETRATING BY INHALATION

  2018cites this paper
• Sulforaphane Inhibits c‐Myc‐Mediated Prostate Cancer Stem‐Like Traits

  2016cites this paper
• c-Myc is a novel target of cell cycle arrest by honokiol in prostate cancer cells

  2016cites this paper
• Cancer preventive effects of tocopherols in dietary carcinogen-induced colon and prostate carcinogenesis models

  2016cites this paper
• Single and Multiple Gene Manipulations in Mouse Models of Human Cancer

  2015cites this paper
• Phage Display Library Screening for PSA-/lo Prostate Cancer Cell-Binding Peptides

  2014cites this paper
• Disruption of Prostate Epithelial Differentiation Pathways and Prostate Cancer Development

  2013cites this paper
• A Cancer-Indicative microRNA Pattern in Normal Prostate Tissue

  2013cites this paper
• Genetically engineered mouse models of prostate cancer

  2013influential citation
• Murine Models of Prostate Cancer

  2013cites this paper
• Photodynamic agents with anti-metastatic activities.

  2013cites this paper
• Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer

  2013cites this paper
• Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches

  2013cites this paper
• Pim kinase inhibitors sensitize prostate cancer cells to apoptosis triggered by Bcl-2 family inhibitor ABT-737.

  2012cites this paper
• Cancer Genes and Genomics Caveolin-1 Upregulation Contributes to c-Myc – Induced High-Grade Prostatic Intraepithelial Neoplasia and Prostate Cancer

  2012cites this paper
• Statins in Prostate Cancer: Prevention and Treatment

  2012cites this paper
• Caveolin-1 Upregulation Contributes to c-Myc–Induced High-Grade Prostatic Intraepithelial Neoplasia and Prostate Cancer

  2011cites this paper
• The tumorigenicity-promoting activity of C-FABP in prostate cancer cells depends on its fatty acid-binding ability

  2011cites this paper
• Modeling human prostate cancer in genetically engineered mice.

  2011cites this paper
• Tea polyphenols as prostate cancer preventive agents

  2011cites this paper
• c-Myc Regulates Self-Renewal in Bronchoalveolar Stem Cells

  2011cites this paper
• MYC and Prostate Cancer.

  2010cites this paper
• Modeling prostate cancer: a perspective on transgenic mouse models

  2010cites this paper
• MYC Overexpression Induces Prostatic Intraepithelial Neoplasia and Loss of Nkx3.1 in Mouse Luminal Epithelial Cells

  2010influential citation
• Faithfull modeling of PTEN loss driven diseases in the mouse.

  2010cites this paper
• Androgen receptor signaling pathway in prostate cancer

  2010cites this paper
• ETS Transcription Factors Control Transcription of EZH2 and Epigenetic Silencing of the Tumor Suppressor Gene Nkx3.1 in Prostate Cancer

  2010cites this paper
• Development of an in vitro model for investigating the properties of human prostate epithelial cells and prostatic carcinoma cells

  2009cites this paper
• Molecular Pathogenesis of Prostate Cancer: Somatic, Epigenetic, and Genetic Alterations

  2009cites this paper
• Interactions between Cells with Distinct Mutations in c-MYC and Pten in Prostate Cancer

  2009cites this paper
• Molecular cancer phenotype in normal prostate tissue.

  2009cites this paper
• Causes and consequences of genomic instability in prostatic carcinogenesis.

  2009cites this paper
• Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate.

  2009cites this paper
• TITLE : FoxP 3 Functions as a Novel Breast Cancer Suppressor Gene Through Cooperation with NFAT PRINCIPAL INVESTIGATOR :

  2009cites this paper
• Development and characterisation of novel mouse models of human prostate cancer

  2008cites this paper
• Transcription profiling of lung adenocarcinomas of c-myc-transgenic mice: Identification of the c-myc regulatory gene network

  2008cites this paper
• Molecular Alterations in Prostate Cancer as Diagnostic, Prognostic, and Therapeutic Targets

  2008cites this paper
• Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis

  2008cites this paper
• Genetic changes and DNA damage responses in the prostate

  2008cites this paper
• Prostatic preneoplasia and beyond.

  2008cites this paper
• CLASSIFICATION OF TESTICULAR GERM CELL TUMORS : INSIGHTS FROM IMMUNOHISTOCHEMISTRY

  2008cites this paper
• Animal Models of Prostate Cancer

  2008cites this paper
• Molecular markers in the diagnosis of prostate cancer

  2007cites this paper
• Charakterisierung einer neuen Amplifikationseinheit auf Chromosom 3q25-q26 beim Prostatakarzinom mit Hilfe molekular-zytogenetischer und quantitativer PCR-Techniken

  2007influential citation
• Advances in preclinical investigation of prostate cancer gene therapy.

  2007cites this paper
• p53 and DNA damage checkpoint responses in the human prostate

  2007cites this paper
• Molecular markers in the diagnosis of prostate cancer.

  2007cites this paper
• Molecular basis for androgen independency in prostate cancer

  2006cites this paper
• Integrative biology of prostate cancer progression.

  2006cites this paper
• PTEN and GSK3β: key regulators of progression to androgen-independent prostate cancer

  2006cites this paper
• PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer.

  2006cites this paper
• Transgenic mice for Cre‐inducible overexpression of the oncogenes c‐MYC and Pim‐1 in multiple tissues

  2006cites this paper
• Combined c‐Myc and caveolin‐1 expression in human prostate carcinoma predicts prostate carcinoma progression

  2005cites this paper
• Genetically engineered murine models of prostate cancer: insights into mechanisms of tumorigenesis and potential utility.

  2005cites this paper
• Genetic alterations in prostate cancer.

  2005cites this paper
• Unopposed c‐MYC expression in benign prostatic epithelium causes a cancer phenotype

  2005cites this paper
• c-Myc Deregulation Promotes a Complex Network of Genomic Instability

  2005cites this paper
• Survey of genetically engineered mouse models for prostate cancer: Analyzing the molecular basis of prostate cancer development, progression, and metastasis

  2005cites this paper
• Genetically defined mouse models that mimic natural aspects of human prostate cancer development.

  2004cites this paper
• Mouse vs human prostate : the realities of comparative anatomy Anatomy and histology of the prostate

  2004cites this paper
• Prostate cancer chemoprevention: models, limitations and potential (Review).

  2004cites this paper
• Prostatic intraepithelial neoplasia and intestinal metaplasia in prostates of probasin‐RAS transgenic mice

  2004cites this paper
• Environmental, genetic, and molecular features of prostate cancer.

  2004cites this paper
• Genetically modified mice and their use in developing therapeutic strategies for prostate cancer.

  2004cites this paper
• Integrated, molecular engineering approaches to develop prostate cancer gene therapy.

  2003cites this paper
• Animal models of prostate cancer.

  2003cites this paper
• Mouse strains for prostate tumorigenesis based on genes altered in human prostate cancer.

  2003cites this paper
• Myc-driven murine prostate cancer shares molecular features with human prostate tumors.

  2003cites this paper
• Myc confers androgen-independent prostate cancer cell growth.

  2003cites this paper
• Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase I safety study in humans.

  2003cites this paper
• Research article: merging bottom-up and top-down approaches to study prostate cancer biology

  2002cites this paper
• Mouse models of prostate carcinogenesis.

  2002cites this paper
• Inhibition of human chorionic gonadotropin β‐subunit modulates the mitogenic effect of c‐myc in human prostate cancer cells

  2002cites this paper
• Prostate cancer: status of current treatments and emerging antisense-based therapies.

  2002cites this paper
• Novel expression patterns of the myc/max/mad transcription factor network in developing murine prostate gland.

  2001cites this paper
• Autochthonous mouse models for prostate cancer: past, present and future.

  2001cites this paper
• Mxi1, a Myc antagonist, suppresses proliferation of DU145 human prostate cells

  2001cites this paper